
Nicolas Girerd
@nicolasgirerd
Heart Failure Specialist @CHRU_de_Nancy | Director @CiCPNancy | Professor @Univ_Lorraine | Chairperson Obesity & Metabolic Committee #HFA_ESC | #HeartFailure
ID: 1584298695318798337
23-10-2022 21:41:07
754 Tweet
492 Followers
281 Following

Iron deficiency and supplementation in patients with heart failure: Results from the IRON‐HF international survey Nicolas Girerd Luca Monzo European Society of Cardiology Journals @INICRCT F-CRIN #CardioTwitter onlinelibrary.wiley.com/doi/10.1002/ej…

Have a 👀 to these interesting results of a survey focusing on iron. Antonio Cannata' @mewton_nathan

Hope we provide some clarity on the evidence related to MRA in the cardio renal field. SABOURETCardiologist Jean-Michel Tartière

Opening of the #MOSAIC meeting in Washington by Faiez ZANNAD. 😁 to discuss the liver heart kidney metabolism interactions in the next 2 days ! SABOURETCardiologist @JJheart_doc GICC HFAPresident Gianluigi Savarese


Let’s add a L to CKM. CKLM concept by Faiez ZANNAD in #MOSAIC 2024 nature.com/articles/s4159… @JJheart_doc SABOURETCardiologist GICC HFAPresident


Faiez ZANNAD on #composite endpoints. (Think Bouillabaisse 🇫🇷!) #Mosaic2024 #TrialDesign


Nicolas Girerd This is a great editorial indeed. Congratulations 🎊







Excellent examples of Implementation hybrid trials. The slides describe the CRHCP trial to improve BP control with excellent outcomes and significant BP reductions. #CVCT2024 CVCT - CardioVascular Clinical Trialists



EMPRESS-MI: Empagliflozin vs placebo, n=105 w/ LVSD (mean LVEF 34.8%) post-AMI (24wks): ↔️LVESVI, LVEDVI, LVEF, LAVI, LVMI ↔️NT-proBNP, hs-TnI ↗️Hct ↘️urate, weight 🔗 doi.org/10.1002/ejhf.3… Jaclyn Carberry Kieran Docherty Mark Petrie Colin Berry University of Glasgow Heart Failure Research Group UofG SCMH

